331 related articles for article (PubMed ID: 28056936)
1. A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis.
Geusens P; Pavelka K; Rovensky J; Vanhoof J; Demeester N; Calomme M; Vanden Berghe D
BMC Musculoskelet Disord; 2017 Jan; 18(1):2. PubMed ID: 28056936
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.
Lugo JP; Saiyed ZM; Lane NE
Nutr J; 2016 Jan; 15():14. PubMed ID: 26822714
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin.
Barel A; Calomme M; Timchenko A; De Paepe K; Demeester N; Rogiers V; Clarys P; Vanden Berghe D
Arch Dermatol Res; 2005 Oct; 297(4):147-53. PubMed ID: 16205932
[TBL] [Abstract][Full Text] [Related]
4. Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.
Klocke R; Levasseur K; Kitas GD; Smith JP; Hirsch G
Rheumatol Int; 2018 Mar; 38(3):455-459. PubMed ID: 29396701
[TBL] [Abstract][Full Text] [Related]
5. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.
Karsdal MA; Byrjalsen I; Alexandersen P; Bihlet A; Andersen JR; Riis BJ; Bay-Jensen AC; Christiansen C;
Osteoarthritis Cartilage; 2015 Apr; 23(4):532-43. PubMed ID: 25582279
[TBL] [Abstract][Full Text] [Related]
6. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.
Karsdal MA; Byrjalsen I; Bay-Jensen AC; Henriksen K; Riis BJ; Christiansen C
BMC Musculoskelet Disord; 2010 Jun; 11():125. PubMed ID: 20565725
[TBL] [Abstract][Full Text] [Related]
8. Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial.
Spector TD; Calomme MR; Anderson SH; Clement G; Bevan L; Demeester N; Swaminathan R; Jugdaohsingh R; Berghe DA; Powell JJ
BMC Musculoskelet Disord; 2008 Jun; 9():85. PubMed ID: 18547426
[TBL] [Abstract][Full Text] [Related]
9. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
[TBL] [Abstract][Full Text] [Related]
10. Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.
Henrotin Y; Berenbaum F; Chevalier X; Marty M; Richette P; Rannou F
BMC Musculoskelet Disord; 2017 May; 18(1):222. PubMed ID: 28549430
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
[TBL] [Abstract][Full Text] [Related]
12. Effect of Mud-Bath Therapy on Serum Biomarkers in Patients with Knee Osteoarthritis: Results from a Randomized Controlled Trial.
Pascarelli NA; Cheleschi S; Bacaro G; Guidelli GM; Galeazzi M; Fioravanti A
Isr Med Assoc J; 2016; 18(3-4):232-7. PubMed ID: 27228651
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study.
Reed K; Collaku A; Moreira S
Curr Med Res Opin; 2018 Apr; 34(4):689-699. PubMed ID: 29239664
[TBL] [Abstract][Full Text] [Related]
14. Cartilage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase-3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis.
Hao HQ; Zhang JF; He QQ; Wang Z
Osteoarthritis Cartilage; 2019 May; 27(5):726-736. PubMed ID: 30391538
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee.
Stebbings S; Gray A; Schneiders AG; Sansom A
BMC Complement Altern Med; 2017 Aug; 17(1):416. PubMed ID: 28830491
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
[TBL] [Abstract][Full Text] [Related]
17. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance therapy for knee osteoarthritis: a randomized, double blind placebo controlled trial.
Gökşen N; Çaliş M; Doğan S; Çaliş HT; Özgöçmen S
Eur J Phys Rehabil Med; 2016 Aug; 52(4):431-9. PubMed ID: 26799573
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial evaluating transdermal Ibuprofen for moderate to severe knee osteoarthritis.
Varadi G; Zhu Z; Blattler T; Hosle M; Loher A; Pokorny R; Frey D; Carter SG
Pain Physician; 2013; 16(6):E749-62. PubMed ID: 24284856
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study.
Kuah D; Sivell S; Longworth T; James K; Guermazi A; Cicuttini F; Wang Y; Craig S; Comin G; Robinson D; Wilson J
J Transl Med; 2018 Mar; 16(1):49. PubMed ID: 29510712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
